Back to Search
RAZELLE KURZROCK, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1477651651Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
21377(WI)
Research & Publications (20)
A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancer.
PMID 19499186·Invest New Drugs·2010
3-trial
Phase 1 first-in-human clinical study of S-trans,trans-farnesylthiosalicylic acid (salirasib) in patients with solid tumors.
PMID 19484470·Cancer Chemother Pharmacol·2010
3-trial
The changing face of phase 1 cancer clinical trials: new challenges in study requirements.
PMID 19165808·Cancer·2009
4-observational
A phase I clinical trial of darinaparsin in patients with refractory solid tumors.
PMID 19584162·Clin Cancer Res·2009
3-trial
Turmeric and green tea: a recipe for the treatment of B-chronic lymphocytic leukemia.
PMID 19228716·Clin Cancer Res·2009
8-other
Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors.
PMID 19546406·J Clin Oncol·2009
3-trial
The role of investigational therapy in management of patients with advanced metastatic malignancy.
PMID 19064962·J Clin Oncol·2009
5-case
Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice.
PMID 19509267·Mol Cancer Ther·2009
7-preclinical
Molecular imaging of Bcr-Abl phosphokinase in a xenograft model.
PMID 19258427·Mol Cancer Ther·2009
7-preclinical
Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2.
PMID 19671848·Clin Cancer Res·2009
7-preclinical
Project Zero Delay: a process for accelerating the activation of cancer clinical trials.
PMID 19652061·J Clin Oncol·2009
8-other
Survival of patients in a Phase 1 Clinic: the M. D. Anderson Cancer Center experience.
PMID 19165805·Cancer·2009
8-other
Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experience.
PMID 19437507·Am J Hematol·2009
8-other
Electronic clinical challenges and images in GI. Image 2. Extensive bilateral extracranial subcutaneous fluid collection.
PMID 19427926·Gastroenterology·2009
5-case
Poor prognosis in non-Caucasian patients with early-onset mycosis fungoides.
PMID 19026464·J Am Acad Dermatol·2009
8-other
Decitabine effect on tumor global DNA methylation and other parameters in a phase I trial in refractory solid tumors and lymphomas.
PMID 19470736·Clin Cancer Res·2009
3-trial
Determination of minimum effective dose and optimal dosing schedule for liposomal curcumin in a xenograft human pancreatic cancer model.
PMID 19528445·Anticancer Res·2009
7-preclinical
The influence of tumor necrosis factor-alpha -308 G/A and IL-6 -174 G/C on pain and analgesia response in lung cancer patients receiving supportive care.
PMID 18990769·Cancer Epidemiol Biomarkers Prev·2008
8-other
Phase I study of epigenetic modulation with 5-azacytidine and valproic acid in patients with advanced cancers.
PMID 18829512·Clin Cancer Res·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9200 W WISCONSIN AVE
MILWAUKEE, WI 53226 - Phone
- (414) 805-0505
Quick Facts
- NPI
- 1477651651
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile